TCT-730 Five-year risk of target lesion revascularization in patients with and without an acute coronary syndrome treated with drug-eluting stents: a pooled analysis of individual participant data from three randomized SORT OUT trials

MLA

Svend Eggert Jensen, et al. “TCT-730 Five-Year Risk of Target Lesion Revascularization in Patients with and without an Acute Coronary Syndrome Treated with Drug-Eluting Stents: A Pooled Analysis of Individual Participant Data from Three Randomized SORT OUT Trials.” Journal of the American College of Cardiology, vol. 70, Oct. 2017, p. B310. EBSCOhost, https://doi.org/10.1016/j.jacc.2017.09.965.

APA

Svend Eggert Jensen, Steen Dalby Kristensen, Lisette Okkels Jensen, Henrik Steen Hansen, Manan Pareek, Michael Maeng, Evald Høj Christiansen, Anders Junker, Bent Raungaard, Morten Madsen, & Karsten Tange Veien. (2017). TCT-730 Five-year risk of target lesion revascularization in patients with and without an acute coronary syndrome treated with drug-eluting stents: a pooled analysis of individual participant data from three randomized SORT OUT trials. Journal of the American College of Cardiology, 70, B310. https://doi.org/10.1016/j.jacc.2017.09.965

Chicago

Svend Eggert Jensen, Steen Dalby Kristensen, Lisette Okkels Jensen, Henrik Steen Hansen, Manan Pareek, Michael Maeng, Evald Høj Christiansen, et al. 2017. “TCT-730 Five-Year Risk of Target Lesion Revascularization in Patients with and without an Acute Coronary Syndrome Treated with Drug-Eluting Stents: A Pooled Analysis of Individual Participant Data from Three Randomized SORT OUT Trials.” Journal of the American College of Cardiology 70 (October): B310. doi:10.1016/j.jacc.2017.09.965.